Oral sirolimus to prevent restenosis after stenting de novo coronary lesions

被引:0
|
作者
Costantini, CR [1 ]
Zanuttini, D [1 ]
Tarbine, S [1 ]
Darwich, R [1 ]
Lazarte, JL [1 ]
Costantini, CO [1 ]
Maranhao, M [1 ]
Andrade, M [1 ]
Oliveira, MR [1 ]
Sabattini, L [1 ]
Yared, G [1 ]
Bubna, M [1 ]
Medeiro, M [1 ]
Rubbini, L [1 ]
Freitas, M [1 ]
机构
[1] Clin Cardiol C Costantini, Curitiba, Parana, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:24A / 25A
页数:2
相关论文
共 50 条
  • [41] Sirolimus-eluting stent to prevent restenosis in diabetic patients with de novo coronary stenoses: the diabetes trial - Nine-month intravascular ultrasound results
    Quevedo, P. Jimenez
    Sabate, M.
    Angiolillo, D.
    Costa, M.
    Alfonso, F.
    Hernandez-Antolin, R.
    Gomez-Hospital, J. A.
    Macaya, C.
    EUROPEAN HEART JOURNAL, 2005, 26 : 711 - 712
  • [42] COMPARISON OF DE-NOVO AND RESTENOSIS CORONARY-ARTERY LESIONS - AN INTRAVASCULAR ULTRASOUND STUDY
    LUO, H
    NISHIOKA, T
    FORRESTER, JS
    KIM, CJ
    BERGLUND, H
    SIEGEL, RJ
    CIRCULATION, 1995, 92 (08) : 78 - 78
  • [43] Long-term clinical outcomes after intravascular brachytherapy for instent restenosis and de novo coronary artery lesions in percutaneous coronary intervention
    Ho, Hee Hwa
    Kwok, On Hing
    Jim, Man Hong
    Siu, Chung Wah
    Pong, Vincent
    Chow, Wing Hing
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2011, 12 (03) : 152 - 157
  • [44] A History of Prior Bare Metal Stent Restenosis Is Associated with Major Adverse Cardiac Events in Subsequent Bare Metal Stenting of de novo Coronary Lesions
    Ferguson, Michael A.
    Needleman, Matthew
    Mitchell, Eric S.
    Carter, Luther I.
    Bustamante, Alexander I.
    Love, Kathleen M.
    Curran, Michael J.
    CARDIOLOGY, 2010, 116 (03) : 190 - 193
  • [45] Restenosis rates following bifurcation stenting with sirolimus-eluting stents for do novo Narrowings
    Tanabe, K
    Hoye, A
    Lemos, PA
    Aoki, J
    Arampatzis, CA
    Saia, F
    Lee, CH
    Degertekin, M
    Hofma, SH
    Sianos, G
    McFadden, E
    Smits, PC
    van der Giessen, WJ
    de Feyter, P
    van Domburg, RT
    Serruys, PW
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01): : 115 - 118
  • [46] The sirolimus-eluting stent is effective for in-stent restenosis as for de novo lesions: Angioscopic comparison of neointimal proliferation
    Awata, Masaki
    Kotani, Jun-ichi
    Nanto, Shinsuke
    Uematsu, Masaaki
    Morozumi, Takakazu
    Watanabe, Tetsuya
    Onishi, Toshinori
    Iida, Osamu
    Sera, Fusako
    Minumiguchi, Hitoshi
    Akahori, Hirokuni
    Yano, Masamichi
    Yasui, Hiroki
    Nagata, Seiki
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 175M - 175M
  • [47] Randomized comparison of direct and provisional stenting in de novo coronary artery lesions: the RADICAL study
    Weber, F
    Schneider, H
    Warzok, F
    Petzsch, M
    von Knorre, GH
    Nienaber, CA
    ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (02): : 173 - 181
  • [48] The Sirolimus PK trial: A pharmacologic study of the Sirolimus-eluting BX velocity stent in patients with de novo coronary lesions
    Vetrovec, GW
    Rizik, D
    Goudreau, E
    Cowley, M
    Malloy, W
    Lipinski, M
    Fernandez, C
    Piotrovskij, V
    Lonzetta, L
    Kopia, G
    Helbig, J
    Drum, D
    CIRCULATION, 2002, 106 (19) : 355 - 355
  • [49] Sirolimus PK trial: A pharmacokinetic study of the sirolimus-eluting bx velocity stent in patients with de novo coronary lesions
    Vetrovec, GW
    Rizik, D
    Williard, C
    Snead, D
    Piotrovski, V
    Kopia, G
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 67 (01) : 32 - 37
  • [50] Progression of new coronary lesions but not restenosis limits the outcome after coronary artery stenting in diabetes mellitus.
    Germing, A
    Dryander, SV
    Bojara, W
    Lawo, T
    Machraoui, A
    Lemke, B
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 39G - 40G